Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Same adding on lows now
Amazing how this stock is soo predictable for shorts....shoots up and then just a steady dump down again. Wish it would change
Go back down posts. December 3rd boatload coming
Very possible, share unlock, tax loss selling , decaying sector .... be watching for buy low sell high scenario
As we analyzed in "Lack Of Ambition Poses Long-Term Hurdles", we think CVSI could be investing more in its business to position for the future. After reading the Q3 transcript, it seems that the company has no concrete solution other than hoping that the FDA will publish new regulations in 2020. There are two issues with that approach. First of all, hoping for new regulations is never a winning strategy given the uncertain timing and details of any future regulation. Secondly, we are not even sure if any FDA regulation could help alleviate market crowdedness as it simply eliminates illegal products, not all competitions. What investors want to hear is how the company plans to innovate and build a stronger brand in an increasingly busy market. The overall impression from the Q3 earnings call is CVSI is blaming the market and regulator for the recent stumble while offering no solutions other than the status quo. Its closest competitor, Charlotte's Web, also reported a poor quarter with flat revenue and falling profits due to investment in personnel and infrastructure. However, CWEB's shares have performed much better than CVSI likely due to its focus on investing in the future and its ambition of becoming a leading CPG company in the CBD category. We think the status quo is not enough and investors are demanding more from incumbents.
Soo true
https://www.google.com/amp/s/seekingalpha.com/amp/article/4309539-cv-sciences-best-defense-offense
Thnx, great product no doubt...time will tell my friend!!
Gonna be watching here after December 3rd share unlock... hmmm
Hey deswag, thnx brother...I have a tight stop loss set here, a shame what happened to cvsi,
Good buy Greenwillow!!!
https://ibb.co/v4DgqcH
Dear Valued Partner,
We’re reaching out to address the FDA’s recent Consumer Communication and Warning Letters related to CBD. CV Sciences supports their enforcement actions against companies who make unsubstantiated claims that CBDcontaining products can treat cancer, Alzheimer’s disease, opioid withdrawal, etc. These companies put consumers at risk, while giving responsible companies, who have done their due diligence, a black eye.
That said, we are disappointed in the alarmist tone used by the FDA in their consumer update, which was released simultaneously with the Warning Letters, regarding the safety of CBD, in that they did not differentiate the vast range of products, servings, and ingredient forms. We agree with the FDA in that there are currently products that raise safety concerns due to their high levels of CBD or that are being marketed to children. As an industry leader, CV Sciences has conducted scientific studies (CVSI GRAS + J. Toxicology) on our specific hemp extract, made through a proprietary process, and considered the levels of CBD and our target consumer population to determine a safe amount that raises none of the potential health risks identified by FDA.
At CV Sciences, consumer safety is our top priority. The FDA stated that it cannot conclude that CBD is generally recognized as safe (GRAS) and this is because a GRAS affirmation is directly linked to a specific ingredient and conditions of use (serving size, age restrictions, etc.). To this point, we can share our research that supports the safety of our specific ingredients for our intended consumer. We believe that the FDA’s statements that CBD is not GRAS are directed toward companies that have piggy-backed on our research, without addressing the significant differences in ingredients, products, levels of CBD and serving size recommendations.
Furthermore, we advocate that the industry limits CBD to dietary supplements and topical products only—not as a food additive. We took this stance at the May 31, 2019 FDA public meeting and continue to support it. We’re optimistic that the FDA shares our goal to create a clear, regulatory path for science-based, hemp-derived CBD ingredients as dietary supplements, that provide an appropriate and safe level of CBD. Lastly, we welcome the opportunity for the FDA to draft regulation allowing for CBD as a dietary supplement, provided the industry, as a whole, responsibly steps up with sound science and research.
Questions? I’m available to address all of the above and to provide further clarification. Please contact Anissa Medina to schedule a call: anissa.medina@cvsciences.com.
Sincerely,
Stuart Tomc, Vice President, Regulatory Science & Education
CV Sciences, PlusCBD™ Oil
Anyone who has been here long see a bottom here? Thanks
3 points here;
1. Use to hold this when it was in the $4, and $5 range.
2. Best product out there use it steady even works better than my medical CBD from a doctors center
3. Started a position today at $1.16, way too cheap...will add more if we drop GLTA
What a shame the stock got poisoned by this sector
Good news
https://ibb.co/X3fF0ch
Ouch!!!
Agree!!!
Thnx , lol I’ve done that a lot too.
Of course no one knows, I’ll wait and see GL
What happens with every stock and a share unlock? Answer is.... selling and cheaper shares, plan accordingly! See chart below
https://ibb.co/dWT2n8T
Yep, Looking to buy after share unlock in December on the discount
The purchase was made on Nov 20th, at the time the price was $2.36 usd per share
Pinch and widen, thin strip at top of page with purchase info by President Fallows
https://ibb.co/4JcNWsd
$VGW, $VGWCF. Very nice to see insider buying! Thank you Jeffrey Fallows, great to see confidence in Valens being backed up by being an investor like many of us. Appreciated and doesn’t go unnoticed!!! Two thumbs up
https://ibb.co/4JcNWsd
$LABS, $MEDIF good take on LABS...for those who didn’t see it
https://ibb.co/3m2kt03
https://ibb.co/sCJ80Cd
Agree 100%, been accumulating cheapies and will continue if market chooses to dip this.
Question to longs here: regarding Nasdaq, confused to criteria and price minimum for uplisting. Has LABS met this already? Or do we have to hit it still? Read conflicting material on this and am still at a loss!
Yes in deed, see my post on 11/20/19 20:53
3 Under-the-Radar Cannabis Stocks With Massive Upside Potential
https://www.nasdaq.com/articles/3-under-the-radar-cannabis-stocks-with-massive-upside-potential-2019-11-22
3 Under-the-Radar Cannabis Stocks With Massive Upside Potential
https://www.nasdaq.com/articles/3-under-the-radar-cannabis-stocks-with-massive-upside-potential-2019-11-22
$VGW Altacorp notes on VGW earnings
Altacorp has a C$10.25 PT & Outperform
Read the Note
https://ibb.co/BgN3YZR
Lol ??
Unlock is December 3rd, earnings are basically sell the news in this sector.... so timing this between both is a battle between all here, GL
Share unlock...we all know what happens #TCNNF #GTBIF
Agree 200%, keep adding
I’m out at even, don’t play share unlocks too risky and people dumping already
Same old SH!T
Thank you!!
Please let me know what you find, appreciate it